These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36618946)

  • 1. Trilateral association of autophagy, mTOR and Alzheimer's disease: Potential pathway in the development for Alzheimer's disease therapy.
    Subramanian A; Tamilanban T; Alsayari A; Ramachawolran G; Wong LS; Sekar M; Gan SH; Subramaniyan V; Chinni SV; Izzati Mat Rani NN; Suryadevara N; Wahab S
    Front Pharmacol; 2022; 13():1094351. PubMed ID: 36618946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
    Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
    J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.
    Uddin MS; Stachowiak A; Mamun AA; Tzvetkov NT; Takeda S; Atanasov AG; Bergantin LB; Abdel-Daim MM; Stankiewicz AM
    Front Aging Neurosci; 2018; 10():04. PubMed ID: 29441009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential.
    Zhang W; Xu C; Sun J; Shen HM; Wang J; Yang C
    Acta Pharm Sin B; 2022 Mar; 12(3):1019-1040. PubMed ID: 35530153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of mTOR: a culprit of Alzheimer's disease?
    Cai Z; Chen G; He W; Xiao M; Yan LJ
    Neuropsychiatr Dis Treat; 2015; 11():1015-30. PubMed ID: 25914534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Implications of Autophagy in Alzheimer's Disease.
    Hamano T; Hayashi K; Shirafuji N; Nakamoto Y
    Curr Alzheimer Res; 2018; 15(14):1283-1296. PubMed ID: 30289076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR signaling and Alzheimer's disease: What we know and where we are?
    Davoody S; Asgari Taei A; Khodabakhsh P; Dargahi L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14463. PubMed ID: 37721413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Autophagy as a Target in the Treatment of Alzheimer's Disease.
    Sose PM; Doshi GM; Kale PP
    Curr Drug Targets; 2023; 24(7):547-567. PubMed ID: 37070441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy Modulation in Aggresome Formation: Emerging Implications and Treatments of Alzheimer's Disease.
    Rahman MA; Rahman MDH; Mamun-Or-Rashid ANM; Hwang H; Chung S; Kim B; Rhim H
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Moxibustion at acpoints of governor vessel on regulating PI3K/Akt/mTOR signaling pathway and enhancing autophagy process in APP/PS1 double-transgenic Alzheimer's disease mice].
    Zhang LD; Han W; Zhu CF; Song XG; Cheng H; Yang K; Qin XF; Zhang JY; Gui L
    Zhongguo Zhen Jiu; 2019 Dec; 39(12):1313-8. PubMed ID: 31820607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting autophagic clearance: viable therapeutic targets in Alzheimer's disease.
    Friedman LG; Qureshi YH; Yu WH
    Neurotherapeutics; 2015 Jan; 12(1):94-108. PubMed ID: 25421002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
    J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy modulation for Alzheimer's disease therapy.
    Zhu XC; Yu JT; Jiang T; Tan L
    Mol Neurobiol; 2013 Dec; 48(3):702-14. PubMed ID: 23625314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease.
    Meur S; Mukherjee S; Roy S; Karati D
    Mol Neurobiol; 2024 Dec; 61(12):10941-10955. PubMed ID: 38816674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles.
    Deng Z; Dong Y; Zhou X; Lu JH; Yue Z
    Acta Pharm Sin B; 2022 Apr; 12(4):1688-1706. PubMed ID: 35847516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.